A
Price
$144.38
Change
+$0.54 (+0.38%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
40.94B
4 days until earnings call
Intraday BUY SELL Signals
ILMN
Price
$120.07
Change
-$1.90 (-1.56%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
18.35B
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

A vs ILMN

Header iconA vs ILMN Comparison
Open Charts A vs ILMNBanner chart's image
Agilent Technologies
Price$144.38
Change+$0.54 (+0.38%)
Volume$25.71K
Capitalization40.94B
Illumina
Price$120.07
Change-$1.90 (-1.56%)
Volume$30.39K
Capitalization18.35B
A vs ILMN Comparison Chart in %
View a ticker or compare two or three
VS
A vs. ILMN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and ILMN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (A: $144.40 vs. ILMN: $121.97)
Brand notoriety: A: Not notable vs. ILMN: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 107% vs. ILMN: 86%
Market capitalization -- A: $40.94B vs. ILMN: $18.35B
A [@Medical Specialties] is valued at $40.94B. ILMN’s [@Medical Specialties] market capitalization is $18.35B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 3 FA rating(s) are green whileILMN’s FA Score has 2 green FA rating(s).

  • A’s FA Score: 3 green, 2 red.
  • ILMN’s FA Score: 2 green, 3 red.
According to our system of comparison, A is a better buy in the long-term than ILMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 2 TA indicator(s) are bullish while ILMN’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 2 bullish, 6 bearish.
  • ILMN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ILMN is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -4.70% price change this week, while ILMN (@Medical Specialties) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.75%. For the same industry, the average monthly price growth was -1.62%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

A is expected to report earnings on Nov 24, 2025.

ILMN is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Medical Specialties (-2.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($40.9B) has a higher market cap than ILMN($18.4B). A has higher P/E ratio than ILMN: A (33.74) vs ILMN (26.93). A YTD gains are higher at: 8.160 vs. ILMN (-10.110). A has higher annual earnings (EBITDA): 1.8B vs. ILMN (1.27B). A has more cash in the bank: 1.54B vs. ILMN (1.28B). ILMN has less debt than A: ILMN (2.58B) vs A (3.41B). A has higher revenues than ILMN: A (6.79B) vs ILMN (4.29B).
AILMNA / ILMN
Capitalization40.9B18.4B222%
EBITDA1.8B1.27B141%
Gain YTD8.160-10.110-81%
P/E Ratio33.7426.93125%
Revenue6.79B4.29B158%
Total Cash1.54B1.28B120%
Total Debt3.41B2.58B132%
FUNDAMENTALS RATINGS
A vs ILMN: Fundamental Ratings
A
ILMN
OUTLOOK RATING
1..100
7978
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
63100
SMR RATING
1..100
4430
PRICE GROWTH RATING
1..100
2140
P/E GROWTH RATING
1..100
196
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for ILMN (67). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

A's Profit vs Risk Rating (63) in the Biotechnology industry is somewhat better than the same rating for ILMN (100). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

ILMN's SMR Rating (30) in the Biotechnology industry is in the same range as A (44). This means that ILMN’s stock grew similarly to A’s over the last 12 months.

A's Price Growth Rating (21) in the Biotechnology industry is in the same range as ILMN (40). This means that A’s stock grew similarly to ILMN’s over the last 12 months.

ILMN's P/E Growth Rating (6) in the Biotechnology industry is in the same range as A (19). This means that ILMN’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AILMN
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 8 days ago
61%
Bullish Trend 20 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
A
Daily Signal:
Gain/Loss:
ILMN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QDTY43.610.41
+0.94%
YieldMax Nasdaq 100 0DTE Cove CllStgyETF
XTJL37.690.07
+0.19%
Innovator US Equity Acclrtd Pls ETF Jul
FEZ61.33-0.11
-0.18%
SPDR® EURO STOXX 50 ETF
FID20.03-0.08
-0.42%
First Trust S&P Int Div Aristocrats ETF
CXSE40.53-0.33
-0.82%
WisdomTree China ex-State-Owd Entpr ETF

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with A. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
-1.52%
A - ILMN
64%
Loosely correlated
+0.39%
RVTY - ILMN
64%
Loosely correlated
-0.87%
MTD - ILMN
62%
Loosely correlated
+0.57%
TMO - ILMN
61%
Loosely correlated
-0.39%
BRKR - ILMN
60%
Loosely correlated
+1.71%
More